Topics

Catalent to Acquire MaSTherCell

03:00 EST 3 Feb 2020 | Contract Pharma

Adds capabilities and technologies for the development and manufacture of autologous and allogeneic cell therapies, as well as related analytical services

Original Article: Catalent to Acquire MaSTherCell

NEXT ARTICLE

More From BioPortfolio on "Catalent to Acquire MaSTherCell"

Quick Search